Contour Xt - Οδηγός Χρήστη

84277763_CntrXT_UG_EL_FpBp_v2.
indd ofc1
7mm min.
1/30/12 9:01 AM
FC: 19.5 mm BC: 10 mm

Footer: N/A
1/3rd of Cross clear
space has been applied
18211 NE 68th Street, E120

Redmond, WA 98052
T: 425-881-5454
BAN#:84277763 Rev. 01/12

Contour XT User Guide - Greece
Alt#1 - 1/25/12 copy changes
Alt#2 - 01/30/12 copy changes
DATE: January 30, 2012

CLIENT: Bayer HealthCare
DESCRIPTION: Contour XT User Guide - Greek
SCHAWK JOB#:
SKU#:
DIMENSIONS:
PRINTER SPEC:
FONTS:
COLORS:
907977
7267 Parent BAN# 84190986
6.0 (H) x 4.5 (W)
10000008206 Rev 01
Myriad Pro, Helvetica, Zapf Dingbats, Times, Frutiger
Cyan
Magenta
Yellow
Black
Clinical Trial / Global Master Template No: XXXX

Regional Master Template No: M_GDE_USR_0051_R0001
NOTE: THIS COLOR PROOF INDICATES COLOR BREAK ONLY AND MAY NOT ACCURATELY REFLECT ACTUAL PRODUCTION COLOR.
RELEASE: V-2
INTERNAL: R-X
LANGUAGE(S): GREEK
2
4
5
:
CONTOURXT

. in vitro .

10 mg/dL 600 mg/dL.
CONTOUR XT
.
:

.

, ,
.

,

.1
13, .
MICROLET2
. .
84277763_CntrXT_UG_EL_FpBp_v2.indd ifc2-3
7
9
10
13
14
,
(L-1)
(L-2)
,

:
:
18
22
23
27
28
30
32
35
37
38
39
44
45
47
21

&
CONTOUR XT,
MICROLET2
.
,
.
.

.
1/30/12 9:02 AM
CONTOURXT
(/
,
,
)
CONTOURNEXT
MICROLET2
84277763_CntrXT_UG_EL_FpBp_v2.indd 4-5
,

.
,
( 32 34).
.

.

12 .

.

.

.
.

/.

. .

.
mg/dL.

7 .

.

7 .

.
.
.

. , , .
10 .
10 ,
.
1/28/12 4:52 PM
:
CONTOUR XT .
.
: CONTOUR XT No Coding,
.

.

. ,
.
.

.
.
. .
"" . .
:
CONTOUR XT
.

mg/dL (
). ,
mmol/L
( ).
mg/dL .
mmol/L .
:

mg/dL. ,
Bayer 801 11 40 200.
: CONTOUR XT
.
, 21 27.
4

. .

. ,
20

.
5C 45C.

CONTOURXT!

.

.

. ,

.
.
5
1/28/12 4:52 PM
. :
CONTOUR XT, CONTOUR NEXT ,
MICROLET2 MICROLET.
CONTOUR NEXT
.
CONTOUR NEXT .
.
,
.
Bayer 801 11 40 200
.

, 7 12.

1. .
2. CONTOURNEXT .
3.
.
4.

.
MICROLET2
.

.
.

, .
MICROLET
,
.
,
CONTOUR XT ,
.. .

UL
TUV.
1.

MICROLET2

,
.
2.

90 ,
.

MICROLET
.
CONTOURXT CONTOURNEXT
; 801 11 40 200
www.bayerdiabetes.gr
7
1/28/12 4:52 PM
3.

.
,
.

.
1.

.
4.

.

.
2.

.

.
5.

.
6.

.
.
3.

.

; 801 11 40 200
9
1/28/12 4:52 PM
4. .
.
6.
,
.

.
20
.
, E2.

.
5. ,
5

.

,
.
:
.
(L-2) 21 22.
,
.
10

, , ,
.
, 70
110 mg/dL .2

.

50 mg/dL
( 10 mg/dL)
,
.

250 mg/dL
( 600 mg/dL)
,
.

CONTOURXT.
; 801 11 40 200

,
.

,

.
11
1/30/12 9:02 AM
1. ,

,
,

,
.
CONTOURXT
( )
, 1
9 .
.

,
.
.
2.

Bayer .
3.

,

.
4.
(),
(),

.
12
5.

.

.

MICROLET .
; 801 11 40 200
13
1/28/12 4:52 PM

CONTOUR NEXT .
14
:
.
.
.

.
,
.
CONTOUR NEXT Bayer.
.
CONTOUR NEXT,
Bayer Diabetes Care
801 11 40 200.
1. .
2.
.
:
. .
5.
.
6.

,
..
.

.
7.
.
.
8.
.
3.
.
4.

.
CONTOUR NEXT
Bayer (, )
CONTOUR XT.
.

,

.
; 801 11 40 200
15
1/28/12 4:52 PM

5

.

,
, .
" " 34.
:
.
.
.

.

7 .
:

,
CONTOURNEXT.
9.

.
; 801 11 40 200
16
,
.

.
17
1/28/12 4:52 PM
CONTOUR XT
, .
12 24 ,
/ /,

.
,
, M 3
. ,
.
,
d.m .

(m/d
/ d.m
.).

24H
,
12 (
) 24 .
M .

.

.
M .
,
.

.
M .
, .

.
M .
12
,
AM PM.
.
18
M .
M .
,
.
v .
M .
, .

.
M .
; 801 11 40 200
19
1/28/12 4:52 PM

.

,
CONTOURXT .
(L-1)
(L-2)

7
14
480

7
7, 14 30
480

30

(2,5; 2,0; 1,5; 1,0 )

.

:
1. M

.
.
2.
3 .
3. L-2.
4.
L-1.
5. M .

,

:
1. M
.

.
2.
3
.
3. L-1.
4.
L-2.
5. M .
M .
,

.

,
M .

,

M .

(
L-1),

.
(L-1)
(L-2)
,

.
(L-1)
(L-2)
20
21
1/28/12 4:52 PM
LO 72 mg/dL.
,

LO,
M .

60 - 90 mg/dL.
,

HI 180 mg/dL.
,

.
M .
100 - 250 mg/dL.

,

. 2,5; 2,0; 1,5;
1,0 ()
(

2,0 ). M .
(L-2 )

.
,
CONTOURXT

.

CONTOURXT
!

,

.
=

.
=

.
=

,
.

.
22

.
; 801 11 40 200
23
1/28/12 4:52 PM

,
.
.

, M .
.

.

.

, M.

.

,
. M
.
, .
20

,
.

.

( 7).
,
.

, M.

,
.
.

,
.

. .
.
.
, . M .
,

. M .
24
; 801 11 40 200
25
1/28/12 4:53 PM
, M
v .

.
v
CONTOURXT ,
.
,
Bayer GLUCOFACTS Deluxe
Bayer. v
www.bayerglucofacts.com
Bayer 801 11 40 200.

.
M
.
: CONTOUR XT
Bayer
Bayer. Bayer

.
()
()
()
26
()

.
.

(1,0 2,5 )

.

.
.
27
1/28/12 4:53 PM
14

.

14 .

7 .
,

HI 180 mg/dL
LO
72 mg/dL
7

.
480 .
v ,

.
M v . ,
3 .

.

.

.

.
; 801 11 40 200
28
M .
M .

,

.
29
1/30/12 9:02 AM
(L-2), , .
M .
M v
14
.
.
.

.

.

,
.

M v . M
14

.

7 .
,

HI LO.

.

30 .

.

30

.

30

.
v
7 .
30

.
M . ,

3 .
; 801 11 40 200
31
1/28/12 4:53 PM
(
)
(
10

)
E1
E2
E3

&
E4
20
.

: 5C 45C.

20
.

.

.

.

.
.

.

.

.
,

CONTOUR NEXT.

(
7).
E5 E9
E6 E12
E8 E13

.
,

Bayer 801 11 40 200.
E7

. CONTOURNEXT
Bayer.
E10

.
18 19
.
,

Bayer 801 11 40 200.
E11

.

,
.

CONTOUR NEXT Bayer.
HI

600 mg/dL.

.
.
HI,
.
250 mg/dL
.
LO

10 mg/dL.
.
LO,
.
50 mg/dL
.
32
; 801 11 40 200
33
Bayer 801 11 40 200.
Technical,
&
Service
& Care
1/28/12 4:53 PM

(
).

.

.

.

.

.

.
.

3.
,
Bayer
801 11 40 200.

(mg/dL).

Bayer
801 11 40 200.

&
34

CONTOUR NEXT
Bayer.

,

Bayer
801 11 40 200.

,

(

, 32).
1.

.
2.

.
:
5 ,
.
5 ,
,
.
3.

,

.
; 801 11 40 200
35

&
,
Bayer 801 11 40 200.
1/28/12 4:53 PM
5.
,
,
.
,
.

, .

.

, , , .
13.
[
3 Volt
(DL2032 CR2032).]

.
.
,
.

.

&
36
; 801 11 40 200
37

&
4.

''+"
.
1/28/12 4:53 PM

&
, .
:
: /
: 0,6 L
: 10 - 600 mg/dL
: 5
: 480
: 3 Volt, 225 mAh
(DL2032 CR2032)
: 1000 (
1 )
:
: 10 93% RH
: 77 mm () x 57 mm () x 19 mm ()
: 47,5 (1,7 oz.)
: v , ,
,
.
.
,
.
(): CONTOURXT

ISO 15197: 2003.

,
CONTOUR XT. H
IEC 61000-4-2: 2008.
.
CONTOUR XT
ISO 15197: 2003. CONTOUR XT
, , ,

, .
,
:3

():

():
():

,
.
50 mg/dL 250 mg/dL,
.
,
.
38
; 801 11 40 200
39

&
1/30/12 9:03 AM

&
:

. .
:
6.301 .
:
.
: >1168 mg/dL
>4709 mg/dL .
:
CONTOUR NEXT.
:
.
.
:

. , ,

.5
:
( , )
( , ) .
.
40
'

CONTOURXT ( ,
).
(
)

In Vitro

.

.

.
.

.
; 801 11 40 200
41

&
: CONTOUR NEXT

.
.
-- FAD
(FAD-GDH) v .
,
. v , . .
: CONTOUR XT
.
. :
( 5 7% ).4
1/30/12 9:03 AM
CONTOUR XT
100
( CONTOUR NEXT).
YSI,
CDC.
.

CONTOURXT

30 40 mg/dL. (n=100)

CONTOUR XT
CONTOURNEXT. .
1
<75 mg/dL

CONTOUR XT CONTOUR NEXT
( )

5 mg/dL
48 54
(88,9%)

10 mg/dL
54 54
(100,0%)

15 mg/dL*
54 54
(100,0%)
2 -
75 mg/dL

YSI
CONTOUR XT

&
( )

5%

10%

15%
, %
41,0
0,7
1,8
74,8
1,4
1,9
117,2
1,5
1,3
190,8
2,2
1,2
307,2
5,3
1,7

YSI
CONTOUR XT

20%*
439 546 544 546 546 546 546 546

(80,4%)
(99,6%)
(100,0%)
(100,0%)
* ISO 15197: 2003 95%

(, ) 15 mg/dL
75 mg/dL, 20%
75 mg/dL.
42
; 801 11 40 200
43

&
, mg/dL
1/30/12 9:03 AM

, Bayer
801 11 40 200:
.
: Bayer HealthCare
, Bayer HealthCare
, ,
.
: -

Bayer:

&
2.

CONTOUR NEXT .
_______________________
6HULDO1R
1000001
1000001

CONTOURNEXT Bayer
84190986
mg/dL PS
Bayer Consumer Care AG

Peter Merian-Strasse 84
4052 Basel,
Switzerland
7267
Serial No.
1/
1
1.
(A) (B)
.
_______________________
_______________________
Re
v.
0
T: 801 11 40 200
0
69

77
842
PJG/ 36
3.
. ( 35, .)
44
1. /
90 .
2. . Bayer HealthCare

, ,
, , ,
Bayer HealthCare
. , Bayer HealthCare

Bayer HealthCare
Bayer (.. CONTOURNEXT) Bayer HealthCare.
3. Bayer HealthCare ,

.
4. Bayer HealthCare CONTOUR XT,
CONTOUR NEXT,
CONTOURXT,

CONTOUR NEXT CONTOUR NEXT
.
; 801 11 40 200
45
CONTOUR XT CONTOUR NEXT , .

CONTOUR NEXT.

&

Bayer
. .
1/28/12 4:53 PM

5. Bayer HealthCare
CONTOUR XT ,
CONTOUR NEXT.
BAYER HEALTHCARE
.
BAYER HEALTHCARE .
BAYER ,
, BAYER
HEALTHCARE
.
:
Bayer
801 11 40 200 /
.
,

.

40030030
3 Volt DL2032 CR2032
84277763
CONTOURXT
84191389
CONTOURNEXT
84185206
CONTOUR NEXT,
84185230
CONTOUR NEXT,
84185222
CONTOUR NEXT,
* .

&
Protection of Laboratory Workers from Occupationally Acquired

Infections; Approved GuidelineThird Edition. Clinical and
Laboratory Standards Institute (CLSI), document M29-A3,
(ISBN 1-56238-567-4). CLSI, 940 West Valley Road, Suite 1400,
Wayne, Pennsylvania 19087-1898, USA 2005.
Longo DL, et al.: Harrisons Principles of Internal Medicine,

18th edition. 2011:3003
American Diabetes Association, www.diabetes.org
Tietz Fundamentals of Clinical Chemistry, 5th Edition, Edited by

Burtis CA and Ashwood ER, W. B. Saunders Co., Philadelphia, PA,
2001, p. 444.
Atkin, S. et al.: Fingerstick Glucose Determination in Shock.

Ann. Int. Med. 114:1020-24; 1991.
; 801 11 40 200
47

&
46
1/28/12 4:53 PM
1/28/12 4:53 PM
:
Bayer ,
,
18-20,
151 25

801 11 40 200 ( )
Bayer Consumer Care AG

Peter Merian-Strasse 84
4052 Basel, Switzerland
Bayer, Bayer, CONTOUR, GLUCOFACTS,

MICROLET Bayer. No Coding
No Coding
Bayer. YSI YSI Incorporated.

.
2012 Bayer. .
4277763_CntrXT_UG_EL_FpBp_v2.indd obc52
0088
84277763
Rev. 01/12
1/28/12 4:53 PM

Contour Xt - Οδηγός Χρήστη

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Contour Xt - Οδηγός Χρήστη

Uploaded by

Copyright:

Available Formats

84277763_CntrXT_UG_EL_FpBp_v2.

FC: 19.5 mm BC: 10 mm

18211 NE 68th Street, E120

BAN#:84277763 Rev. 01/12

DATE: January 30, 2012

Clinical Trial / Global Master Template No: XXXX

Bayer 801 11 40 200.

439 546 544 546 546 546 546 546

* ISO 15197: 2003 95%

Bayer Consumer Care AG

CONTOUR XT CONTOUR NEXT , .

3 Volt DL2032 CR2032

Protection of Laboratory Workers from Occupationally Acquired

Longo DL, et al.: Harrisons Principles of Internal Medicine,

American Diabetes Association, www.diabetes.org

Tietz Fundamentals of Clinical Chemistry, 5th Edition, Edited by

Atkin, S. et al.: Fingerstick Glucose Determination in Shock.

Bayer Consumer Care AG

Bayer, Bayer, CONTOUR, GLUCOFACTS,

You might also like